| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,245 |
983 |
$76K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,445 |
1,107 |
$56K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
511 |
425 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,395 |
581 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,403 |
1,070 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
992 |
746 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
60 |
56 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
484 |
404 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
13 |
$866.86 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
636 |
477 |
$591.37 |
| 87807 |
|
78 |
59 |
$533.82 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
832 |
638 |
$111.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
25 |
22 |
$22.06 |